Download PDF
CC BY-NC-ND 4.0 · Ibnosina Journal of Medicine and Biomedical Sciences 2023; 15(01): 033-036
DOI: 10.1055/s-0042-1750181
Original Article

Assessing the Knowledge of Sick-Day Rules Among Patients on Long-Term Glucocorticoids and Healthcare Professionals in a UK District General Hospital

Muhammad Masoud Alam
1   Abu Dhabi Stem Cells Research Center, Abu Dhabi, United Arab Emirates
,
Mohammad Tariq 
2   Health Bay Day Surgery, Dubai, United Arab Emirates
,
L. N. Rao Bondugulapati 
3   YAS Clinic, Khalifa City, Abu Dhabi, United Arab Emirates
,
Mohammed Afraz Pasha
4   North Alabama Medical Center, Florence, Alabama, United States
,
Jawad Bashir 
5   King's College Hospital London, Dubai, United Arab Emirates
,
Usman Hassan
6   Nobles Hospital, Isle of Man, United Kingdom
,
Tufail Ahmad Awan 
7   Nobles Hospital, Isle of Man, United Kingdom
› Author Affiliations Funding and Sponsorship None.
› Further Information
   Permissions and Reprints

Abstract

Introduction Adrenal insufficiency can happen because of decreased cortisol production as a result of negative feedback on the hypothalamic–pituitary–adrenal axis, caused by excess exogenous glucocorticoids (GC). The most common cause of adrenal insufficiency is, in fact, abrupt stoppage of exogenous GC. Patients with adrenal insufficiency are at risk of developing life-threatening adrenal crisis if GC is reduced or stopped abruptly, or if GC dose is not increased during periods of increased stress.

The adrenal crises should be preventable with education of patients and healthcare professionals (HCPs) about “sick-day” rules, the importance of “steroid cards,” and the utility of parenteral steroids.

Methods This study was aimed at assessing the knowledge of sick-day rules in patients on long-term GC as well as HCPs.

Patients aged above 18 years on long-term GC presenting to the endocrinology clinic over 6 weeks were included after audit-committee approval.

Results We assessed 18 consecutive patients in total, 61% (11/18) of whom said that they have received information about sick-day rules from an HCP. Only 38% (7/18) had access to emergency hydrocortisone-kit.

We assessed 36 HCPs. Thirty-six (13/36) percent were aware of steroid emergency card and 50% (18/36) HCPs exhibited awareness regarding steroid dose during acute event and 27% of (10/36) HCPs were aware of accessible hospital intranet resources.

Conclusion This study revealed significant lack of awareness of sick-day rules among patients and HCPs alike. Majority of patients failed to carry steroid emergency card or medic alert bracelet and majority of HCPs and patients lacked knowledge of sick-day rules.

Keywords

adrenal insufficiency - glucocorticoid - healthcare professionals - patients - steroids

Authors' Contribution

All authors contributing to data collection and writing/reviewing the article.


Compliance with Ethical Principles

Audit was internal audit committee approved and no ethical approval required as it was an audit.




Publication History

Article published online:
19 July 2022

© 2022. The Libyan Biotechnology Research Center. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Liu D, Ahmet A, Ward L. et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 2013; 9 (01) 30
    CrossrefPubMedGoogle Scholar
  • 2 Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 1992; 326 (04) 226-230
    CrossrefPubMedGoogle Scholar
  • 3 Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet 2014; 383 (9935): 2152-2167
    CrossrefPubMedGoogle Scholar
  • 4 Sagar R, Mackie S, W Morgan A. Stewart P, Abbas A. Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatment. Clin Endocrinol (Oxf) 2021; 94 (03) 361-370
    CrossrefPubMedGoogle Scholar
  • 5 van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM 2000; 93 (02) 105-111
    CrossrefPubMedGoogle Scholar
  • 6 Laugesen K, Jørgensen JOL, Sørensen HT, Petersen I. Systemic glucocorticoid use in Denmark: a population-based prevalence study. BMJ Open 2017; 7 (05) e015237 DOI: 10.1136/bmjopen-2016-015237.
    CrossrefPubMedGoogle Scholar
  • 7 Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken) 2013; 65 (02) 294-298
    CrossrefPubMedGoogle Scholar
  • 8 Laugesen K, Jørgensen JOL, Petersen I, Sørensen HT. Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark. Eur J Endocrinol 2019; 181 (03) 267-273
    CrossrefPubMedGoogle Scholar
  • 9 Broersen LH, Pereira AM, Jørgensen JO, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab 2015; 100 (06) 2171-2180
    CrossrefPubMedGoogle Scholar
  • 10 Erichsen MM, Løvås K, Fougner KJ. et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol 2009; 160 (02) 233-237
    CrossrefPubMedGoogle Scholar
  • 11 Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 2006; 91 (12) 4849-4853
    CrossrefPubMedGoogle Scholar
  • 12 Quinkler M, Beuschlein F, Hahner S, Meyer G, Schöfl C, Stalla GK. Adrenal cortical insufficiency–a life threatening illness with multiple etiologies. Dtsch Arztebl Int 2013; 110 (51-52): 882-888
    CrossrefPubMedGoogle Scholar
  • 13 Kampmeyer D, Lehnert H, Moenig H, Haas CS, Harbeck B. A strong need for improving the education of physicians on glucocorticoid replacement treatment in adrenal insufficiency: an interdisciplinary and multicentre evaluation. Eur J Intern Med 2016; 33: e13-e15
    CrossrefPubMedGoogle Scholar
  • 14 Kampmeyer D, Haas CS, Moenig H, Harbeck B. Self-management in adrenal insufficiency - towards a better understanding. Endocr J 2017; 64 (04) 379-385
    CrossrefPubMedGoogle Scholar
  • 15 Grounds K, Khan I, Adlan M, Premawardhana L. Poor knowledge of safety aspects of long-term steroid use among patients and healthcare professionals. Clin Med (Lond) 2017; 17 (04) 378-380
    CrossrefPubMedGoogle Scholar
  • 16 Mehta P, Meeran K, Macphie E. et al. Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice. Lancet Rheumatol 2021; 3 (02) e92-e94
    CrossrefPubMedGoogle Scholar
  • 17 Wass JAH, Howell TH, Arlt W, Pearce S. 2011. Addison's disease.. Potentially life-threatening steroid dependency. Addison's Disease Self Help Group. 2011.
  • 18 Erskine D, Simpson H. (on behalf of Specialist Pharmacy Service & Society for Endocrinology). Exogenous steroids, adrenal insufficiency and adrenal crisis – who is at risk and how should they be managed safely. 2021 https://www.endocrinology.org/media/4030/spssfe_supporting_sec_-final_hls-19022021-2-1.pdf. Accessed May 7, 2022
    PubMedGoogle Scholar